Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
K27M mutation in histone H3.3 defines clinically...
Journal article

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas

Abstract

Pediatric glioblastomas (GBM) including diffuse intrinsic pontine gliomas (DIPG) are devastating brain tumors with no effective therapy. Here, we investigated clinical and biological impacts of histone H3.3 mutations. Forty-two DIPGs were tested for H3.3 mutations. Wild-type versus mutated (K27M-H3.3) subgroups were compared for HIST1H3B, IDH, ATRX and TP53 mutations, copy number alterations and clinical outcome. K27M-H3.3 occurred in 71 %, …

Authors

Khuong-Quang D-A; Buczkowicz P; Rakopoulos P; Liu X-Y; Fontebasso AM; Bouffet E; Bartels U; Albrecht S; Schwartzentruber J; Letourneau L

Journal

Acta Neuropathologica, Vol. 124, No. 3, pp. 439–447

Publisher

Springer Nature

Publication Date

September 2012

DOI

10.1007/s00401-012-0998-0

ISSN

0001-6322